Preferred Pharmaceuticals, Inc.: Drug Recall
Recall #D-0342-2021 · 04/12/2021
Class II: Risk
Recall Details
- Recall Number
- D-0342-2021
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Preferred Pharmaceuticals, Inc.
- Status
- Ongoing
- Date Initiated
- 04/12/2021
- Location
- Anaheim, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- Six bottles
Reason for Recall
Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin
Product Description
Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only, Repackaged by Preferred Pharmaceuticals, Inc., Mfg: Ascend Laboratories, LLC, NDC #: 68788-7529-1,
Distribution Pattern
recalled product was distributed to three physicians located CA
Other Recalls by Preferred Pharmaceuticals, Inc.
- Class II: Risk 11/17/2025
- Class II: Risk 04/18/2025
- Class II: Risk 08/08/2024
- Class II: Risk 05/10/2024
- Class II: Risk 06/26/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.